These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 21666337

  • 21. Intravitreal bevacizumab injection in patients with choroidal neovascularization due to choroid rupture after blunt-head trauma.
    Artunay O, Rasier R, Yuzbasioglu E, Sengül A, Bahcecioglu H.
    Int Ophthalmol; 2009 Aug; 29(4):289-91. PubMed ID: 18825317
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta.
    Rishi P, Rishi E, Venkatraman A.
    Indian J Ophthalmol; 2012 Aug; 60(3):229-31. PubMed ID: 22569391
    [Abstract] [Full Text] [Related]

  • 26. Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses.
    Ruiz-Moreno JM, Montero JA, Amat-Peral P.
    Graefes Arch Clin Exp Ophthalmol; 2011 Apr; 249(4):595-9. PubMed ID: 21234588
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization.
    Mandal S, Garg S, Venkatesh P, Mithal C, Vohra R, Mehrotra A.
    Arch Ophthalmol; 2007 Nov; 125(11):1487-92. PubMed ID: 17998509
    [Abstract] [Full Text] [Related]

  • 34. Intravitreal bevacizumab for a subfoveal myopic choroidal neovascularization in the first trimester of pregnancy.
    Introini U, Casalino G, Cardani A, Scotti F, Finardi A, Candiani M, Bandello F.
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):553-5. PubMed ID: 22662749
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Ach T, Hoeh AE, Ruppenstein M, Kretz FT, Dithmar S.
    Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Serous retinal detachment following combined photodynamic therapy and intravitreal bevacizumab injection.
    Kim EY, Kim JW, Kim JB, Lew HM.
    Korean J Ophthalmol; 2009 Jun; 23(2):124-6. PubMed ID: 19568365
    [Abstract] [Full Text] [Related]

  • 40. Thirty-two month follow-up of successful treatment of choroidal neovascularization from angioid streaks with intravitreal bevacizumab.
    Kovach JL, Schwartz SG, Hickey M, Puliafito CA.
    Ophthalmic Surg Lasers Imaging; 2009 Jun; 40(1):77-9. PubMed ID: 19205505
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.